- Home
- GUTS vs MLSS Comparison
GUTS vs MLSS Comparison
Compare GUTS & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUTS
- MLSS
- Stock Information
- Founded
- GUTS 2010
- MLSS 1989
- Country
- GUTS United States
- MLSS United States
- Employees
- GUTS N/A
- MLSS N/A
- Industry
- GUTS
- MLSS Industrial Specialties
- Sector
- GUTS
- MLSS Health Care
- Exchange
- GUTS NYSE
- MLSS Nasdaq
- Market Cap
- GUTS 110.1M
- MLSS 98.1M
- IPO Year
- GUTS 2024
- MLSS 1995
- Fundamental
- Price
- GUTS $1.80
- MLSS $1.18
- Analyst Decision
- GUTS Buy
- MLSS Buy
- Analyst Count
- GUTS 2
- MLSS 1
- Target Price
- GUTS $18.00
- MLSS $1.25
- AVG Volume (30 Days)
- GUTS 382.2K
- MLSS 263.6K
- Earning Date
- GUTS 02-02-2025
- MLSS 11-14-2024
- Dividend Yield
- GUTS N/A
- MLSS N/A
- EPS Growth
- GUTS N/A
- MLSS N/A
- EPS
- GUTS N/A
- MLSS N/A
- Revenue
- GUTS $97,000.00
- MLSS $8,877,010.00
- Revenue This Year
- GUTS N/A
- MLSS N/A
- Revenue Next Year
- GUTS N/A
- MLSS $17.97
- P/E Ratio
- GUTS N/A
- MLSS N/A
- Revenue Growth
- GUTS N/A
- MLSS N/A
- 52 Week Low
- GUTS $1.74
- MLSS $0.54
- 52 Week High
- GUTS $14.50
- MLSS $1.27
- Technical
- Relative Strength Index (RSI)
- GUTS 40.50
- MLSS 64.68
- Support Level
- GUTS $1.91
- MLSS $1.07
- Resistance Level
- GUTS $2.10
- MLSS $1.27
- Average True Range (ATR)
- GUTS 0.16
- MLSS 0.09
- MACD
- GUTS -0.01
- MLSS 0.02
- Stochastic Oscillator
- GUTS 6.12
- MLSS 80.85
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.